CGS vs PTX

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

CGS

COGSTATE FPO [CGS]

53MEDIUM

PTX

PRESCIENT FPO [PTX]

53MEDIUM

Score Breakdown

CGS PTX
Technical
62
70
Catalyst
50
50
Sentiment
50
50
Fundamental
95
65
Momentum
80
58
Risk Gate
50
50

Key Metrics

CGS Metric PTX
$372.8MMarket Cap$57.8M
89KAvg Volume (20d)1.1M
+0.0%Short InterestN/A
$2.97052-Week High$0.125
$1.21052-Week Low$0.038
+1.9%Daily Change-1.8%
$2.150Entry Price$0.054
+22.5%ROE-54.3%
+19.2%Profit Margin-207.7%

Active Signals

CGS Signals

●Stochastic just turned bullish from a low level — early reversal sign
●Trading below both moving averages — the trend is working against this one
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Moderate P/S ratio (6.6x)
●Moderate revenue growth (+12%)
●Piotroski F-Score strong (8/9, low-confidence approx)

PTX Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Sitting near support — this level has held before and could attract buyers again
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it

Ask Scout AI to compare CGS and PTX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
CGS Full Analysis → PTX Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).